Yeah I also saw that on the news. However CSL expect to release it after the flu season so doubt it will have any immediate effect on sp
bloomberg link said:The drugmaker expects the first batch of its swine flu vaccine to be available in late July or early August, CSL said on its Web site.
CSL Receives USD180 million (approximately AUD230 million) Order from U.S. Government to Produce Novel Influenza A (H1N1) Vaccine
Been trading this one for quite a while. My 2c at this juncture...
I think it's good enough to assume the selling is over at this point. Time to buy if you are brave (I did). The resistance at 30 will be a good test to find out if the rally really has legs.
From the other side of the fence I think it is just a tad early with two EW 3rd wave correctives converging around the $27 mark. The FTC driblings are not helping and it will take some time (Oct-Nov09) for their stupidity to be made lucid before the law; in the meantime marking time allows the market a breath to choose their lead.I'm game to go long. Will use a stop loss this time. Don't want to be trapped on the downside if things go wrong.
Gday everyone, I see reports saying that if the Talecris deal falls through overall it is still not a bad thing and possibly CSL will do a share buy back. Ok as I am an amateur re share market what does this mean. My thoughts have been
1. Offer existing shareholders opportunity to buy shares at lower price.
2. CSL decreases amount of shares registered increasing value of our existing shares.
3. Do existing shareholders get a cash payment dependant of quantity of shares.
I have no idea but appreciate some info.
Thanks
From the other side of the fence I think it is just a tad early with two EW 3rd wave correctives converging around the $27 mark.
Personally I think the probability of a government instrumentality (FTC) getting it wrong has got to be a safe bet. Their "block" has to be tested in the court. Whilst the beaurocrats can hide behind rhetoric they still have to sell the funding of a vigorous court case to the Commissioners and then come up with strong arguments to beat the past precedents on which CSL are assured they can rely.FTC, from memory seems to have a good record in blocking M&A and winning them. The chance of CSL winning this case I believe is quite slim, so it will be big negative on the stock since there's a break fee of 70 million. If they win, the stock price won't go beyond 35 since there's still plenty of work ahead. If they lose, well, it will be 70 + all the legal costs.
FTC, from memory seems to have a good record in blocking M&A and winning them. The chance of CSL winning this case I believe is quite slim, so it will be big negative on the stock since there's a break fee of 70 million. If they win, the stock price won't go beyond 35 since there's still plenty of work ahead. If they lose, well, it will be 70 + all the legal costs.
CSL will be 150m-200m better off after deduct all the costs.
i predict the sp will rise to 38 before the release of their annual report.
A follow up...
Hello and welcome to Aussie Stock Forums!
To gain full access you must register. Registration is free and takes only a few seconds to complete.
Already a member? Log in here.